发明申请
- 专利标题： Treatment of Acute Coronary Syndrome with an Exendin
- 专利标题（中）： 用毒素治疗急性冠状动脉综合征
-
申请号： US12822165申请日： 2010-06-23
-
公开(公告)号： US20100311662A1公开(公告)日： 2010-12-09
- 发明人: Thomas R. Coolidge , Mario Ehlers
- 申请人： Thomas R. Coolidge , Mario Ehlers
- 申请人地址： US CA San Diego
- 专利权人： AMYLIN PHARMACEUTICALS, INC.
- 当前专利权人： AMYLIN PHARMACEUTICALS, INC.
- 当前专利权人地址： US CA San Diego
- 主分类号： A61K38/16
- IPC分类号： A61K38/16 ; A61P9/00
摘要：
The invention relates to methods for treating a patient suffering from acute coronary syndrome, but who is not suffering from a Q-wave myocardial infarction, comprising administration of a therapeutically effective amount of a GLP-1 molecule. The GLP-1 can be self-administered, and can be administered in one or more doses, as needed, on an intermittent or continuous basis, to optimize metabolism in cardiac tissue and to prevent cardiac damage associated with ischemia.
公开/授权文献
- US07981861B2 Method of performing angioplasty with a GLP-1 molecule 公开/授权日：2011-07-19
信息查询
IPC分类:
